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In the present study, the interaction of inhalational and oral exposure to manganese and lead was investigated. Young adult male Wistar rats
(2 x 10 per group) were treated orally with MnCl2 (15 and 60 mg/kg b.w.) or Pb acetate (80 and 320 mg/kg) for 3 or 6 weeks. Then, one
half of the groups was further treated by intratracheal instillation of nanoparticulate MnO2 (2.63 mg/kg) or PbO (2 mg/kg) for an equal
period of time. Body weight gain and signs of general toxicity were regularly checked. Finally, the rats’ motor behavior was tested in an
open field box, and their spontaneous and evoked cortical electrical activity was recorded in urethane anesthesia. MnO2 nanoparticles
caused disproportionately strong reduction of body weight gain but with Pb the weight effect was more dependent on dose. In the open field
test, Mn caused hypomotility, more strongly after 6 weeks oral plus 6 weeks intratracheal than after 6 weeks oral treatment. Pb-treated rats
showed increased ambulation but less rearing and somewhat longer local activity. Spontaneous cortical activity was shifted to higher
frequencies after oral Mn application, but this change was not intensified by subsequent nanoparticle application. Oral Pb had an opposite
effect. Cortical evoked potentials showed latency lengthening. In several cases, the effect of Mn and Pb was about as strong after 3 weeks
oral plus 3 weeks intratracheal as after 6 weeks oral administration, although the summed dose was ca. two times lower in the former case.
There can be a more-than-additive interaction between the amounts of heavy metals entering the organism in different routes and chemical
forms. 
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Introduction 
Chemical risk, resulting from application of metal-based 
and other xenobiotics, is a major problem of our days. 
Numerous metals are regarded as xenobiotics because they 
either are completely useless and toxic for the human 
organism (e.g. mercury, lead or cadmium) or are essential 
micronutrients but toxic when overdosed (manganese, 
chromium, copper, etc.). 
Exposure to heavy metals is mostly occupational. Metal-
containing dusts and fumes are generated along the 
complete life cycle of metal products (e.g. during welding1), 
and can be found in the workplace atmosphere, causing 
exposure primarily via inhalation. The resulting internal 
dose is influenced by chemical form and size of the 
suspended particles. In the last 20 years nanoparticles (NPs) 
and their interaction with living organisms, raised health 
concerns2. Combustion processes and working on materials 
at high temperature generate NPs (particles which are 
smaller than 100 nm at least in one dimension), their 
composition being determined by the materials worked on 
or burnt. Likewise, manufactured nanomaterials contain at 
least one component with at least one dimension in the 1-
100 nm range. 
Inhaled NPs are either deposited in the nasopharynx or get 
down to the alveoli3. NPs are not held back by biological 
barriers like alveolar and capillary wall, are distributed 
throughout the body by blood circulation, and reach distant 
target organs including the central nervous system. The 
NPs’ small size and large specific surface area, together 
with the high numbers of NPs entering the organism in a 
typical exposure situation, result in great biological and 
pathogenetical activity2. 
Apart from inhalation, the second most important route of 
exposure to heavy metals is ingestion. Airborne particles can 
be ingested directly; dust can contaminate food or drink, etc. 
Metals from the sedimenting dust can be incorporated into 
edible parts of cultivated plants, either directly or via soil 
pollution (as it happened near the metal reprocessing plant 
Metallokémia in Budapest4). Ingested heavy metals are 
absorbed in the intestine mostly to ca. 10%. Common metal 
transport mechanisms, responsible for the uptake of 
essential metals, are involved, which explains that  
individuals with increased calcium or iron demand absorb 
more of the toxic metals. Toxic metals are transported as 
“free-riders” not only from the intestine to the blood but also 
from the blood to the central nervous system (CNS). 
Trivalent metal ions, like Mn3+ use transferrin to pass the 
blood-brain barrier. 
Based on practical importance and on previous 
experiences of our research group5,6,7, lead and manganese 
were chosen for the present study. 
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Lead (Pb) has been a ubiquitous environmental pollutant 
for centuries, and is toxic even in low concentrations8. 
Primary production and reprocessing of Pb causes 
substantial emission of metal fumes. Neurological effects 
were observed in workers with chronic Pb exposure: 
headache, lethargy, dizziness, diminished reaction time, 
worsened cognitive and visuomotor performance, and 
reduced nerve conduction velocity9. The general population 
is exposed mainly by contaminated drinking water or food. 
Pb is accumulated in the central nervous system, first in the 
cortex and hippocampus10, and produces encephalopathy. 
Exposure to low concentrations of Pb has been associated 
with behavioral abnormalities, learning and hearing 
impairment and impaired cognitive functions in humans and 
in experimental animals11. Some approximations suggest 
that, in exposed children, every 100 μg/L increase in blood 
Pb level is associated with a 1-5 point decrease in the IQ 
level12, such an effect was observed also in Hungary13. Pb 
can also pass the placenta and cause serious damage to the 
nervous system before birth. 
Manganese (Mn) is an essential micronutrient, e.g. as 
cofactor in metallo-enzymes:. The human body contains 
about 10 mg Mn, stored mainly in the liver and kidneys. The 
daily demand is 2-3 mg14. Mn is used in many important 
alloys, so welding fumes and similar industrial emissions are 
also a source of Mn-containing NPs. Chronic inhalation of 
Mn-containing dust and fumes is the typical form of 
occupational exposure. The Mn-related chronic neurological 
disorder (manganism) starts with apathy, anorexia, headache, 
hypersomnia, weakness of the legs etc. and progresses to a 
Parkinson-like syndrome15. Such disorder was also observed 
in patients undergoing maintenance hemodialysis16 or in 
inadvertent oral overdosing of Mn. Thus, other 
physicochemical forms of Mn and other routes of exposure 
are also relevant to the health of the CNS. In several regions 
of the USA with Mn-rich drinking water, loss of visual and 
verbal memory, typical for Mn-induced brain damage, was 
described17. The neurotoxic spectrum of Mn is variable and 
goes beyond the classical manganism. In shipyard workers, 
EEG and visual evoked potential alterations were observed 
and elevated blood Mn levels were measured18. 
The aim of this work was to model the complex 
(occupational and environmental) human exposure to Mn 
and Pb in rats as a model, with combined – oral and 
intratracheal – administration using dissolved and 
nanoparticulate form of the metals. 
Methods 
Animals and treatment 
Young adult male Wistar rats (initial body weight 280–
350 g) obtained from the Breeding Centre of the University, 
were used for the experiments. 
The animals were housed under standard conditions (22–
24°C, 12 h light/dark cycle with light on at 6:00 a.m., up to 
four rats in one cage) with free access to conventional 
pelleted feed and drinking water 
Aqueous solution of Mn and Pb was given to the rats 
orally by gavage (per os, po.), while the suspension of the 
metals in NP form was instilled in the trachea 
(intratracheally, it.; for details see6. 
Table 1  The substances used for treatment and the doses applied 
Group 
code Substance and dose (mg kg
-1 b.w.) Treatment time 
MnC3 untreated 3 weeks 
MnVC3 distilled water, per os 3 weeks 
MnL3 MnCl24H2O 15 mg kg-1 b.w. po. 3 weeks 
MnH3 MnCl2 60 mg kg-1 b.w. po. 3 weeks 
MnC33 untreated* 6 weeks 
MnVC33 distilled water, po. + HEC (hydroxyethyl cellulose) it. 
3 weeks + 
3 weeks 
MnL33 MnCl2 15 mg kg
-1 b.w. po. + 
MnO2 NPs 2.63 mg kg-1 b.w. it. 
3 weeks + 
3 weeks 
MnH33 MnCl2, 60 mg kg
-1 b.w. po. + 
MnO2 NPs 2.63 mg kg-1 b.w. it. 
3 weeks + 
3 weeks 
MnC6 untreated* 6 weeks 
MnVC6 distilled water, po. 6 weeks 
MnL6 MnCl2 15 mg kg-1 b.w. po. 6 weeks 
MnH6 MnCl2  60 mg kg-1 b.w. po. 6 weeks 
MnC66 untreated 12 weeks 
MnVC66 distilled water, po. + HEC it. 
6 weeks + 
6 weeks 
MnL66 MnCl2, 15 mg kg
-1 b.w. po. + 
MnO2 NPs 2.63 mg kg-1 b.w. it. 
6 weeks + 
6 weeks 
MnH66 MnCl2, 60 mg kg
-1 b.w. po. + 
MnO2 NPs 2.63 mg kg-1 b.w. it. 
6 weeks + 
6 weeks 
Group 
code Substance and dose (mg/kg b.w.) 
Treatment 
time 
PbC3 untreated 3 weeks 
PbVC3 distilled water, po. 3 weeks 
PbL3 Pb(CH3COO)2, 80 mg kg-1 b.w. po. 3 weeks 
PbH3 Pb(CH3COO)2, 320 mg kg-1 b.w. po. 3 weeks 
PbC33 untreated* 6 weeks 
PbVC33 distilled water, po. + 
HEC it. 
3 weeks + 
3 weeks 
PbL33 Pb(CH3COO)2, 80 mg kg-1 b.w. po. + 
PbO NPs 2 mg kg-1 b.w. it. 
3 weeks + 
3 weeks 
PbH33 Pb(CH3COO)2, 320 mg kg-1 b.w. po. 
+PbO NPs 2 mg/kg b.w. it. 
3 weeks + 
3 weeks 
PbC6 untreated* 6 weeks 
PBVC6 distilled water, po. 6 weeks 
PbL6 Pb(CH3COO)2, 80 mg kg-1 b.w. po. 6 weeks 
PbH6 Pb(CH3COO)2, 320 mg kg-1 b.w. po. 6 weeks 
PbC66 untreated 12 weeks 
PbVC66 distilled water, per os + 
HEC it. 
6 weeks + 
6 weeks 
PbL66 Pb(CH3COO)2, 80 mg kg-1 b.w. po. + 
PbO NPs 2 mg kg-1 b.w. it. 
6 weeks + 
6 weeks 
PbH66 Pb(CH3COO)2, 320 mg kg-1 b.w. po. 
+PbO NPs, 2 mg kg-1 b.w. it. 
6 weeks + 
6 weeks 
* C33 and C6 were always two different groups of rats. 
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Chemical identity and dose of the substances applied to 
the rats, along with treatment times, are given in Table 1. 
For intratracheal administration, the NPs were suspended in 
1% hydroxyethyl cellulose dissolved in PBS (pH 7.4). This 
vehicle was physiologically neutral and slowed the 
aggregation of the NPs. There was one administration every 
workday (that is, 5 times a week); body weight was 
measured before every administration to determine the exact 
daily doses and to follow weight gain. 
Behavioral investigation by the open field method 
At the end of the treatment periods, open field (OF) test 
was done, in one 10-min session per rat, to assess their 
spontaneous locomotor activity. The test was performed 
between 8 and 11 hours in the morning, after 30 min 
adaptation to the dimly lighted test room. The instrument 
recorded the animal’s horizontal and vertical motor activity, 
from which counts, time and run length of the activity forms 
(ambulation, local activity, immobility, rearing) were 
automatically calculated (for technical details and suitability, 
see7).  
Electrophysiological investigation 
The electrophysiological recording was done on the same 
day after the OF test or on the following day. The animals 
were anaesthetized by intraperitoneal injection of 1000 
mg/kg b.w. urethane, and the left hemisphere was exposed 
by opening the bony skull. For recording, the rat was placed 
into the stereotaxic frame of the electrophysiological setup. 
Body temperature was maintained by the thermostated 
(+36.5°C) support plate. To record spontaneous and evoked 
cortical activity, a ball-tipped silver recording electrode was 
positioned on the dura over the primary somatosensory (SS) 
area. SS stimulation was done by a pair of needles inserted 
into the whiskery part of the nasal skin, delivering square 
electric pulses. The recording session started with six 
minutes recording of spontaneous activity 
(electrocorticogram, ECoG) first. From the ECoG records, 
the relative spectral power of the frequency bands. Then 
evoked potentials (EPs) from the same cortical site were 
recorded. Electrical stimulation of the whiskers was done by 
delivering rectangular electric stimuli (3-4 V, 0.05 ms). 
Trains of 50 stimuli were applied, one each with 1, 2 and 10 
Hz frequency. Individual EPs were automatically averaged, 
and their latency and duration was measured manually. 
From the general toxicological, behavioral and 
electrophysiological data, group mean values (SD) were 
calculated. All results were checked for normality by means 
of the Kolmogorov-Smirnov test, then were tested for 
significance using one-way ANOVA with post hoc LSD test 
by the SPSS 15.0 for Windows software package. 
Significance was accepted at p<0.05.During the whole study, 
the principles of the Ethical Committee for the Protection of 
Animals in Research of the University were strictly 
followed. The authority competent in animal welfare issues 
licensed the methods used in the experiments under No. 
XXI./02039/001/2006.  
 
Results 
Body weight gain 
Oral Mn treatment had minimal effect on body weight; but 
as soon as it, administration of Mn NPs started, the weight 
gain in the treated groups got substantially slower than 
either in the vehicle-treated (MnVC; Fig. 1) or untreated 
(MnC, not shown) control. Oral Pb had visible effect on 
body weight gain from the 4th week on (Fig. 1) but 
switching to it, administration on the 6th week caused also 
here a marked drop.  
Figure 1. Top: body weight curves of high dose Mn and Pb treated 
rats and the corresponding controls. Middle and bottom: 
relationship of metal dose and weight gain. See Table 1 for group 
coding and doses. 
The relationship between weight gain and summed dose 
was dissimilar: for Mn it was more influenced by the form 
(NP vs. dissolved) but for Pb, more by the summed dose. 
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Open field motility 
Noteworthy changes in OF motility were seen only after 6 
and 6+6 weeks of metal exposure (Fig. 2). Mn decreased 
ambulation and rearing (the latter, only after 6+6 weeks) and 
increased local activity and immobility. Pb caused increased 
ambulation but decreased rearing. 
Figure 2. Time share of the four open field activity forms in the 
total session time (top, Mn treated; bottom, Pb treated rats). 
*, **: p<0.05, 0.01 vs. VC. 
Cortical electrical activity 
The general trend in the electrocorticogram (ECoG) band 
spectra on Mn effect was decrease in the delta, and increase 
in the theta and in the fast (beta, gamma) bands. Similarly to 
the OF effects, these changes were relatively more 
pronounced only after 6 and 6+6 weeks Mn treatment (Fig. 
3). After 6 weeks oral Pb treatment, increased slow and 
decreased fast ECoG activity was seen, compared to the 
control PbVC6. However, in the rats receiving 6+6 weeks 
Pb exposure, this frequency shift disappeared. 
Latency of the SS EP was increased by Mn (Fig. 4). This 
increase was seen at all stimulation frequencies but the slope 
of frequency dependence of the latency (a possible indicator 
of metal-induced cortical fatigability) was not much altered.  
Latency lengthening was of similar magnitude in MnL33 
and MnL6 (and was only slightly more different in MnH33 
vs. MnH6) in spite of the dissimilar summed dose, in 
accordance with the relationship of summed Mn dose and 
body weight (Fig. 1). 
 
 
Figure 3. Band spectrum of the spontaneous activity recorded from 
the somatosensory cortex of rats after 6 and 6+6 weeks of Mn (top) 
and Pb (bottom) exposure. 
*: p<0.051 vs. VC 
Latency of the SS EP was increased in the Pb-treated rats 
(Fig. 5). The change was significant vs. vehicle control in 
rats with 3+3, 6 and 6+6 weeks treatment. The change in 
PbH33 and PbH6 was nearly equal, and in PbL33 
somewhat bigger than in PbL6; indicating that the NP form 
could have disproportionately strong effect on the nervous 
system (but not on body weight, see Fig. 1) also in case of 
Pb. In PbH33 and PbH66, the frequency dependent 
lengthening of latency became also more intense.  
Discussion 
General and neuro-functional parameters indicated 
repeatedly that there could be a non-additive interaction 
between the amounts of heavy metals given by po. and it, 
application.  
In Mn exposure, the disproportionately strong effect of 
NPs was seen on the body weight gain, a general toxic 
parameter. Metal level data from previous comparable 
experiments6,7 suggest that inhaled NPs cause internal 
exposure more efficiently than ingested, dissolved metals. 
Pb is known to affect BBB19, which may explain that, 
among the Pb-treated rats, lengthening of SS EP latency was 
nearly equal in PbH33 and PbH6, despite the ca. twice 
higher summed dose in the 6 weeks po. Pb administration. 
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Figure 4.  Latency of the somatosensory evoked potential in Mn 
treated rats (relative values normalized to VC, 1 Hz).  
*, **, ***: p<0.05, 0.01, 0.001 vs. VC 
°, °°, °°°: p<0.05, 0.01, 0.001 vs. 1 Hz stimulation within the same 
group. 
Figure 5.  Latency of the somatosensory evoked potential in Pb 
treated rats (relative values normalized to VC, 1 Hz).  
*, **, ***: p<0.05, 0.01, 0.001 vs. VC 
°, °°: p<0.05, 0.01 vs. 1 Hz stimulation within the same group. 
 
Metal NPs are always likely to cause oxidative stress. 
Metabolites indicating oxidative damage upon Pb exposure 
were detected in humans20. Generation of reactive oxygen 
species was detected in the brain in case of both Mn and Pb, 
resulting in membrane lipid peroxidation20,21, leading to 
changes of membrane functions, such as synaptic 
transmission, which may be reflected in various forms of 
cortical activity. 
Increased latency in the rats treated with both metals 
might be, at least partly, due to decreased synaptic 
efficiency. Pb2+ and Mn2+ ions block the voltage-gated Ca-
channels in presynaptic endings, impeding this way 
intracellular Ca2+ rise and depolarization on arrival of an 
axonal discharge, and preventing synchronous emptying of 
vesicles. Inside, however, both ions can activate a number of 
Ca-dependent processes including those involved in 
exocytosis, so the spontaneous release of the transmitter will 
be more likely22,23. 
Glutamate, the main excitatory transmitter in the CNS, is 
neutralized by uptake in astrocytes and conversion to 
glutamine; and this uptake is decreased by Mn24 and Pb25. 
Excess glutamate may desensitize the postsynaptic receptors 
leading finally to smaller/slower cortical evoked responses. 
Altered glutamatergic excitation, and energetic shortage 
from mitochondrial effect of the metals, might have opposite 
effect on the ECoG spectrum. The resulting net change was 
in fact different depending on the relative strength of the 
two opposite influences. 
The changes in open field motor behavior may result from 
the general CNS effects, but even more from the 
dopaminergic effects, of the metals or NPs. Motivation, 
determining OF activity, is regulated by 
mesolimbic/mesocortical dopaminergic structures. 
Dopaminergic neurons are especially vulnerable to oxidative 
stress, due to the auto-oxidizing tendency of dopamine and 
to the presence of monoamine oxidase producing hydrogen 
peroxide26 and the metals investigated are known to cause 
oxidative stress as mentioned above. Decreased horizontal 
movements in-group MnH66 is a feature of general 
hypomotility, possibly analogous to the Mn-exposed 
welders’ syndrome27. Increased locomotion of the Pb-treated 
rats may be analogous to the human “attention deficit 
hyperactivity disease” found more frequently among 
children with elevated blood Pb28. 
Conclusion 
The attempt to model a complex metal exposure, coming 
both from environmental (food/waterborne) and 
occupational (inhalational) sources, was apparently 
successful.  With respect to the general use and ubiquitous 
presence of metals, their health effects in general, and in 
particular the nervous system and other sensitive systems, 
are of primary concern. Occurrence of metals in 
nanoparticulate form, let it be nanotechnological materials 
or unwanted pollutants, adds a new feature to the old 
problem. 
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